FLT3 and acute myeloid leukemia: Basic risk stratification and prognostic scoring of AML is based on the presence of mutation within nucleophosmin member 1 gene (NPM1) and/or signal transduction fms-like tyrosine kinase 3 (FLT3) gene, and groups patients into favourable, intermediate, and adverse risk categories7.